MARKET

EVGN

EVGN

Evogene
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.070
+0.040
+3.88%
Closed 16:00 06/01 EDT
OPEN
1.060
PREV CLOSE
1.030
HIGH
1.090
LOW
1.055
VOLUME
4.07K
TURNOVER
--
52 WEEK HIGH
1.830
52 WEEK LOW
0.7500
MARKET CAP
27.56M
P/E (TTM)
-1.5214
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EVGN stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.

EPS

EVGN News

More
Evogene Ltd (EVGN) CEO Ofer Haviv on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 6d ago
Evogene reports Q1 results
Evogene (NASDAQ:EVGN): Q1 GAAP EPS of -$0.24. Revenue of $0.08M (-77.1% Y/Y) Press Release
seekingalpha · 6d ago
Evogene Reports First Quarter 2020 Financial Results
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its financial results for the first quarter, ended March 31, 2020.
PR Newswire · 6d ago
Evogene Launches Its New Branding to Reflect the Company's Expanded Vision and New Business Model
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces today its rebranding. The new corporate identity reflects the company's e
PR Newswire · 05/20 11:00
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020
PR Newswire · 05/07 12:00
Evogene Publishes Letter to Shareholders
PR Newswire · 05/05 12:00
Evogene Files Annual Report for the Year Ended December 31, 2019
PR Newswire · 04/30 12:00
Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides
PR Newswire · 03/25 13:00

Industry

Fishing & Farming
-1.49%
Food & Tobacco
+0.69%

Hot Stocks

Symbol
Price
%Change

About EVGN

Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.
More

Webull offers kinds of Evogene Ltd stock information, including NASDAQ:EVGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVGN stock news, and many more online research tools to help you make informed decisions.